pre-IPO PHARMA

TAG: JP Morgan

Jan 30, 2023

Rakuten Medical Presented at the 41st Annual J.P. Morgan Healthcare Conference on the Progress of its Pipeline including its Newly Added Antibody-Dye Conjugate RM-0256, Commercial Growth in Japan, and Important Milestones for the Next Few Years


Jan 6, 2023

Synthekine Secures $100 Million Series C Financing to Advance Pipeline of Engineered Cytokine Therapeutics


Jan 6, 2023

Orca Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference


Jan 5, 2023

ElevateBio to Present at the 41st Annual J.P. Morgan Healthcare Conference


Jan 5, 2023

Halia Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference



Jan 5, 2023

Mammoth Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference


Jan 5, 2023

Noema Pharma to Attend and Present at 41st Annual J.P. Morgan Healthcare Conference in San Francisco


Jan 5, 2023

Ventus Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference


Jan 5, 2023

ArsenalBio Announces First Patient Dosed in Phase 1 Clinical Trial of AB-1015 in Development as a Treatment for Ovarian Cancer


Jan 5, 2023

Aerami Therapeutics to Present at Biotech Showcase™ 2023 during the 41st Annual J.P. Morgan Healthcare Conference Week



Jan 5, 2023

Affini-T Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference


Jan 5, 2023

Immune-Onc Therapeutics Announces Close of Series B Extension Financing, Bringing Total Round to $131 Million


Jan 4, 2023

Bicara Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference


Jan 4, 2023

AKTIS ONCOLOGY TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE


Jan 4, 2023

Arbor Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference



Jan 4, 2023

Forge Biologics, a Leading Manufacturer of Genetic Medicines, to Present at 41st Annual J.P. Morgan Healthcare Conference


Jan 4, 2023

Frontier Medicines to Present at the 41st Annual J.P. Morgan Healthcare Conference


Jan 4, 2023

Korro Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference


Jan 4, 2023

RayzeBio to Present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023


Jan 4, 2023

Elpiscience to Present Its Novel Immunotherapies at Biotech Showcase™ during J.P. Morgan Week 2023



Jan 4, 2023

Ascidian Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference


Jan 4, 2023

Umoja Biopharma to Present at the 41st Annual J.P. Morgan Healthcare Conference


Jan 3, 2023

ReCode Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference


Jan 3, 2023

Vigil Neuroscience to Present at the 41st Annual J.P. Morgan Healthcare Conference


Jan 3, 2023

LEXEO Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference



Jan 3, 2023

Metagenomi to Present at 41st Annual J.P. Morgan Healthcare Conference


Jan 3, 2023

Rakuten Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 10th, 2023


Jan 3, 2023

Elucida Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference


Jan 3, 2023

Mission Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference


Jan 3, 2023

Nanoscope Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference



Jan 3, 2023

ITM to Present at the 41st Annual J.P. Morgan Healthcare Conference


Dec 28, 2022

Biomica CEO to Attend the JP Morgan Healthcare Week in San Francisco between January 9-11, 2023 USA - English USA - English


Dec 28, 2022

Boundless Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference


Dec 28, 2022

Biomica CEO to Attend the JP Morgan Healthcare Week in San Francisco between January 9-11, 2023


Dec 27, 2022

CG Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference



Dec 20, 2022

ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 41st Annual J.P. Morgan Healthcare Conference


Dec 6, 2022

Systems Oncology to Present Positive Preclinical Data for SERA2 at J.P. Morgan 41st Annual Healthcare Conference


Nov 29, 2022

Insilico Medicine to Present at 41st Annual J.P. Morgan Healthcare Meeting


Jan 11, 2022

Genesis Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 10, 2022

Arrakis Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference



Jan 10, 2022

Immune-Onc Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 10, 2022

ReCode Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference


Jan 10, 2022

Zymergen Debuts Automation Business and Shares Program Portfolio at 40th Annual JP Morgan Healthcare Conference


Jan 10, 2022

Affini-T Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 7, 2022

Shasqi to Present at the 40th Annual J.P. Morgan Healthcare Conference



Jan 6, 2022

ImCheck to Present at 40th Annual J.P. Morgan Healthcare Conference


Jan 6, 2022

ElevateBio to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 6, 2022

AKTIS ONCOLOGY TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE


Jan 6, 2022

RayzeBio to Present at J.P. Morgan Healthcare Virtual Conference on Tuesday, January 11, 2022


Jan 6, 2022

Shape Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference



Jan 6, 2022

Bicara Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference


Jan 6, 2022

Jnana Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference


Jan 6, 2022

Apnimed to Present at the 40th Annual JP Morgan Healthcare Conference


Jan 6, 2022

Mammoth Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference


Jan 6, 2022

Nimbus Therapeutics Announces Expansion of Oral Allosteric TYK2 Inhibitor Program and Provides Additional Business Updates



Jan 6, 2022

Verge Genomics to Present at 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022


Jan 6, 2022

Quell Therapeutics Announces Presentation at the 40th Annual J.P. Morgan Healthcare Conference


Jan 6, 2022

Orca Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 5, 2022

Maze Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 5, 2022

FluGen to Present at the 40th Annual J.P. Morgan Healthcare Conference



Jan 5, 2022

NeoImmuneTech to Present at 2022 Biotech Showcase at J.P. Morgan Healthcare Conference


Jan 5, 2022

Korro Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 5, 2022

Forge Biologics to Present at 40th Annual J.P. Morgan Healthcare Conference


Jan 5, 2022

Frontier Medicines to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 5, 2022

LEXEO Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference



Jan 5, 2022

Rakuten Medical to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 10th, 2022


Jan 5, 2022

Zymergen to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 5, 2022

Asher Bio to Present at 40th Annual J.P. Morgan Healthcare Conference


Jan 5, 2022

Gennao Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 5, 2022

DiscGenics to Present at 40th Annual J.P. Morgan Healthcare Conference



Jan 5, 2022

ITM Isotope Technologies Munich to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 4, 2022

Boundless Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 4, 2022

Affinivax to Present at the 40th Annual J.P. Morgan Healthcare Conference


Jan 4, 2022

ArsenalBio to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference


Jan 4, 2022

AavantiBio to Present at the 40th Annual J.P. Morgan Healthcare Conference



Jan 4, 2022

Lyell Immunopharma to Participate in 40th Annual J.P. Morgan Healthcare Conference


Dec 9, 2021

GRO Biosciences Announces Appointment of Bruce Beutel, PhD to Board of Directors and J.P. Morgan Health Care Conference Week Activities


Dec 6, 2021

PharmAbcine to participate in J.P. Morgan Healthcare Conference and Biotech Showcase during "J.P. Morgan Week 2022"


Jan 14, 2021

Ichnos Sciences To Present At 39th Annual J.P. Morgan Healthcare Conference


Jan 13, 2021

Sigilon Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 14, 2021



Jan 13, 2021

Rafael Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare Conference


Jan 13, 2021

XtalPi to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 12, 2021

Imago BioSciences to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 11, 2021

Blade-Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 11, 2021

PACT Pharma to Present at the 39th Annual J.P. Morgan Healthcare Conference



Jan 11, 2021

Jasper Therapeutics to Present at 39th Annual J.P. Morgan Virtual Healthcare Conference


Jan 11, 2021

ReCode Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference


Jan 11, 2021

Humacyte CEO Dr. Laura Niklason to Present at J.P. Morgan Healthcare Conference January 11


Jan 11, 2021

Blade Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 8, 2021

ElevateBio to Present at the 39th Annual J.P. Morgan Healthcare Conference



Jan 8, 2021

Talaris Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 8, 2021

Graphite Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 8, 2021

ATP and Biolojic Design Launch Aulos Bioscience to Develop Highly Differentiated IL-2 Antibody Approach to Fighting Cancer USA - English USA - English USA - English España - español España - español Deutschland - Deutsch Deutschland - Deutsch France - Français France - Français


Jan 8, 2021

Biomea Fusion to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 8, 2021

Frontier Medicines to Present at the 39th Annual J.P. Morgan Healthcare Conference



Jan 8, 2021

Ginkgo Bioworks CEO to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 8, 2021

ATP and Biolojic Design Launch Aulos Bioscience to Develop Highly Differentiated IL-2 Antibody Approach to Fighting Cancer USA - English Israel - English USA - español USA - Deutsch USA - Français


Jan 7, 2021

Korro Bio to Present at J.P. Morgan Healthcare Conference


Jan 7, 2021

Aligos Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 7, 2021

Affinivax to Present at the 39th Annual J.P. Morgan Healthcare Conference



Jan 7, 2021

Monte Rosa Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference


Jan 7, 2021

Elucida Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 7, 2021

Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021


Jan 7, 2021

Scorpion Therapeutics Announces Oversubscribed $162 Million Series B Financing


Jan 6, 2021

Verve Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference



Jan 6, 2021

Boundless Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference and H.C. Wainwright BioConnect 2021 Conference


Jan 6, 2021

TScan Therapeutics Announces Presentation at the 39th Annual J.P. Morgan Healthcare Conference


Jan 6, 2021

Elevation Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 6, 2021

ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in the 39th Annual J.P. Morgan Healthcare Conference 2021, January 11th - 14th


Jan 5, 2021

LAVA Therapeutics to Present Corporate Overview at 39th Annual J.P. Morgan Healthcare Conference



Jan 5, 2021

Tmunity to Present at the 39th Annual J.P. Morgan Healthcare Conference


Jan 5, 2021

BioAge to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021


Jan 5, 2021

Autobahn Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference


Dec 21, 2020

Atea Pharmaceuticals to Present at 39th Annual J.P. Morgan Healthcare Conference


Dec 21, 2020

Atomwise Announces Growing Portfolio of Joint Venture Companies



Jan 15, 2020

Senti Biosciences to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 13, 2020

Rafael Pharmaceuticals to Present at 38th Annual J.P. Morgan Healthcare Conference


Jan 13, 2020

Ginkgo Bioworks CEO to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 10, 2020

Fusion Pharmaceuticals To Present at The 38th Annual J.P. Morgan Healthcare Conference


Jan 10, 2020

Biomarck Pharmaceuticals to Participate in 38th Annual J.P. Morgan Healthcare Conference on Thursday, January 16th, 2020



Jan 10, 2020

Generation Bio to Present at 38th Annual J.P. Morgan Healthcare Conference


Jan 10, 2020

VERO Biotech, Leaders in the Development of Innovative Technologies for Inhaled Nitric Oxide Delivery, to Present at Biotech Showcase 2020


Jan 10, 2020

Kronos Bio To Present At The 38th Annual J.P. Morgan Healthcare Conference


Jan 10, 2020

Rakuten Medical to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 9, 2020

Adagene to Present at the 38th Annual J.P. Morgan Healthcare Conference



Jan 9, 2020

Nkarta Therapeutics to Present at the J.P. Morgan Healthcare Conference


Jan 9, 2020

Adicet Bio to Present at J.P. Morgan Healthcare Conference


Jan 9, 2020

Tmunity to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 9, 2020

Recursion to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 9, 2020

Landos Biopharma to Present at the 38th Annual J.P. Morgan Healthcare Conference



Jan 8, 2020

Nurix Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 8, 2020

NeuroRx Drug for Suicidal Bipolar Depression Receives Notification of Patent Allowance


Jan 8, 2020

Corvidia Therapeutics to Participate in 38th Annual J.P. Morgan Healthcare Conference


Jan 8, 2020

Checkmate Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 8, 2020

ESCAPE Bio to Present at the 38th Annual J.P. Morgan Healthcare Conference



Jan 8, 2020

American Gene Technologies To Attend J.P. Morgan Healthcare Conference 2020


Jan 7, 2020

Aligos Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 7, 2020

Vapogenix, Developing Non-Opioid Pain Alternatives, Meeting with Investors, Partners During JP Morgan Healthcare Conference Week


Jan 7, 2020

Goldfinch Bio to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 7, 2020

Sigilon Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference



Jan 7, 2020

ImmunityBio to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 6, 2020

Relay Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 6, 2020

ZyVersa Therapeutics' CEO, Stephen C. Glover to Attend the 38th Annual J.P. Morgan Healthcare Conference 2020


Jan 6, 2020

Compass Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 6, 2020

Transcenta to Present at the 38th Annual J.P. Morgan Healthcare Conference



Jan 2, 2020

AskBio to Present at the 38th Annual J.P. Morgan Healthcare Conference


Dec 30, 2019

Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco


Jan 9, 2019

EUSA Pharma Completes Acquisition of Global Rights to SYLVANT (Siltuximab) and Presents Company Update at 37th J.P. Morgan Healthcare Conference


Jan 8, 2019

Systems Oncology to Present at eChinaHealth Event During the 37th Annual J.P. Morgan Healthcare Conference


Jan 7, 2019

Adicet Bio to Present at J.P. Morgan Healthcare Conference on January 9



Jan 7, 2019

Aprea Therapeutics Announces Presentation at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco


Jan 7, 2019

Rafael Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference


Jan 4, 2019

Akero Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference


Jan 4, 2019

Generation Bio to Present at 37th Annual J.P. Morgan Healthcare Conference


Jan 4, 2019

Relay Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference



Jan 4, 2019

Corvidia Therapeutics to Present on Novel Anti-Inflammatory Therapy for Cardio-Renal Disease at J.P. Morgan Healthcare Conference


Jan 4, 2019

REVOLUTION Medicines to Present at the J.P. Morgan Healthcare Conference on January 8, 2019


Jan 3, 2019

Frequency Therapeutics to Present at the 37th Annual JP Morgan Healthcare Conference


Jan 3, 2019

Stoke Therapeutics to Present on First Precision Treatments for Genetic Epilepsies at J.P. Morgan Healthcare Conference


Jan 3, 2019

Oyster Point Pharma to Present at the 37th Annual J.P. Morgan Healthcare Conference



Jan 3, 2019

Compass Therapeutics to Present at J.P. Morgan Healthcare Conference


Jan 3, 2019

Peloton Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference


Jan 2, 2019

BlueRock Therapeutics to Present at the 37th Annual JP Morgan Healthcare Conference


Jan 2, 2019

Morphic Therapeutic to Present at 37th Annual J.P. Morgan Healthcare Conference


Jan 2, 2019

Atreca to Present at the 37th Annual J.P. Morgan Healthcare Conference



Jan 2, 2019

IDEAYA Biosciences to Present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019


Jan 2, 2019

Forbius to Present at the 37th Annual J.P. Morgan Healthcare Conference


Jan 2, 2019

ORIC Pharmaceuticals to Present at J.P. Morgan Healthcare Conference


Jan 2, 2019

FLX Bio to Present at 37th Annual J.P. Morgan Healthcare Conference


Dec 27, 2018

Pliant Therapeutics to Present at 37th Annual J.P. Morgan Healthcare Conference



Dec 21, 2018

Tmunity to Present at the 37th Annual J.P. Morgan Healthcare Conference


Dec 20, 2018

SpringWorks Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference


Jan 10, 2018

CureVac Highlights Key 2018 Corporate Milestones and Outlook


Jan 8, 2018

Amplyx Pharmaceuticals Announces Appointment of CFO and Presentation at the J.P. Morgan 36th Annual Healthcare Conference


Jan 5, 2018

Abide Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference



Jan 5, 2018

IDEAYA Biosciences to Present at the 36th Annual J.P. Morgan Healthcare Conference


Jan 5, 2018

Centrexion Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference


Jan 5, 2018

Ascentage Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference


Jan 5, 2018

SpringWorks Therapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference


Jan 5, 2018

Agilis Biotherapeutics to Present at 36th Annual J.P. Morgan Healthcare Conference



Jan 4, 2018

Rebiotix Participating in Multiple Events During J.P. Morgan 36th Annual Healthcare Conference 2018 Week


Jan 4, 2018

Aprea Therapeutics Announces Presentation at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco


Jan 3, 2018

NeuroRx Retains J.P. Morgan as Financial Advisor


Dec 21, 2017

Hookipa Biotech to Present at 36th Annual J.P. Morgan Healthcare Conference 2018


Jan 6, 2017

Intarcia Therapeutics Announces Upcoming Presentation at 35th Annual J.P. Morgan Healthcare Conference



Jan 6, 2017

Kineta to Present at Biotech Showcase Investor Conference during JP Morgan Week in San Francisco


Jan 5, 2017

Aprea Therapeutics Announces Presentation at the 35th Annual J.P. Morgan Healthcare Conference in San Francisco


Dec 28, 2016

CureVac to Present at the J.P. Morgan 35th Annual Healthcare Conference 2017


Jan 7, 2016

Intarcia Therapeutics Announces Upcoming Presentation at 34th Annual J.P. Morgan Healthcare Conference


Jan 6, 2016

Alcresta Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference



Jan 5, 2016

EnGeneIC Limited to Present at the 34th Annual J.P. Morgan Healthcare Conference


Jan 5, 2016

SELLAS Life Sciences Group to Present at the 34th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2016


Dec 29, 2015

Intrommune Therapeutics to Participate in Meetings with the Investment Community During the 34th Annual JP Morgan Healthcare Conference, January 11-14, 2016


Dec 21, 2015

CureVac to Present at the 34th Annual J.P. Morgan Healthcare Conference


Dec 15, 2015

Apogenix to Present at J.P. Morgan Healthcare Conference



Jan 5, 2015

Trevi Therapeutics to Present at the J.P. Morgan Healthcare Conference


Jan 13, 2014

Intarcia CEO To Present Company Progress, Interim Phase 3 Data, And Key Milestones At J.P. Morgan


Jan 9, 2014

Clarus Therapeutics Presents at 32nd Annual J.P. Morgan Healthcare Conference


Jan 3, 2013

Symphogen to Present at Annual J.P. Morgan Healthcare Conference


Jan 4, 2011

Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference